Norman Schwartz
Chief Executive Officer at BIO-RAD LABORATORIES, INC.
Net worth: 280 M $ as of 2024-03-30
Profile
Norman D. Schwartz is a businessperson who has been at the head of 5 different companies. Currently, Mr. Schwartz occupies the position of Chairman, President & Chief Executive Officer for Bio-Rad Laboratories, Inc. and Chairman for DiaMed France SA, Chairman of Bio-Rad Laboratories AB, Co-Managing Director at Bio-Rad Germany Holding GmbH and President & Director at RainDance Technologies, Inc. (which are all subsidiaries of Bio-Rad Laboratories, Inc.). Mr. Schwartz is also on the board of 7 other companies. In his past career Norman D. Schwartz occupied the position of Group Manager at Clinical Diagnostics, Inc. and Group Manager at Life Science Group, Inc. Mr. Schwartz received an undergraduate degree from San Francisco State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-07 | 432,920 ( 1.85% ) | 150 M $ | 2024-03-30 | |
2024-03-07 | 374,358 ( 7.35% ) | 130 M $ | 2024-03-30 |
Norman Schwartz active positions
Companies | Position | Start |
---|---|---|
BIO-RAD LABORATORIES, INC. | Chief Executive Officer | 2002-12-31 |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Director/Board Member | - |
Bio-Rad AbD Serotec GmbH
Bio-Rad AbD Serotec GmbH Medical SpecialtiesHealth Technology Part of Bio-Rad Laboratories, Inc., Bio-Rad AbD Serotec GmbH is a supplier and manufacturer of antibodies, reagents, and kits. The private company is based in Puchheim, Germany. The German company offers a wide range of custom antibody services, including bulk antibody production, antibody conjugation, and hybridoma production and services. The company's Pioneer Antibody Discovery team of scientists and technical specialists is assigned to every project to ensure a bespoke service tailored according to each client's success criteria. The CEOs of the company are Norman D. Schwartz, Lee Keron Marles. | Chief Executive Officer | - |
Advanced Medical Technology Association
Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC. | Director/Board Member | 2021-02-22 |
Bio-Metrics (U.K.) Ltd.
Bio-Metrics (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1990, Bio-Metrics (U.K.) Ltd. is a British laboratory services company that is part of Bio-Rad Laboratories, Inc. The private company is based in Watford, UK and provides laboratory services. | Director/Board Member | - |
Bio-Rad Services UK Ltd.
Bio-Rad Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Bio-Rad Services UK Ltd. is a private company that specializes in developing, manufacturing, and marketing innovative products for the life science research and clinical diagnostic markets. The company is based in Watford, UK. The British company's products are verified for quality, purity, and performance through certificates of analysis (COAs), which can be obtained by catalog number and lot or batch number. | Director/Board Member | 2016-08-25 |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | President | - |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Director/Board Member | - |
Bio-Rad Germany Holding GmbH
Bio-Rad Germany Holding GmbH Financial ConglomeratesFinance Bio-Rad Germany Holding GmbH engages in the acquisition, disposal, financing, holding, and management of direct and indirect participating interests in firms. It focuses on firms, which specialize in the production and distribution of medical, diagnostic, and other products. The company was founded on March 2, 2009 and is headquartered in Dreieich, Germany. | Chief Executive Officer | 2017-08-03 |
░░░░░░░ ░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Norman Schwartz
Companies | Position | End |
---|---|---|
░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Norman Schwartz
San Francisco State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BIO-RAD LABORATORIES, INC. | Health Technology |
Private companies | 17 |
---|---|
Life Science Group, Inc. | Health Technology |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | Health Technology |
Bio-Metrics (U.K.) Ltd.
Bio-Metrics (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1990, Bio-Metrics (U.K.) Ltd. is a British laboratory services company that is part of Bio-Rad Laboratories, Inc. The private company is based in Watford, UK and provides laboratory services. | Health Technology |
Advanced Medical Technology Association
Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC. | Commercial Services |
Diamed (G.B.) Ltd.
Diamed (G.B.) Ltd. Medical DistributorsDistribution Services Founded in 1975, Diamed (G.B.) Ltd. is a medical diagnostic product distributor. Part of Bio-Rad Laboratories, Inc., the private company is based in Watford, UK. Diamed (G.B. was acquired by Bio-Rad Laboratories, Inc. on December 15, 2008. | Distribution Services |
DiaMed France SA
DiaMed France SA Packaged SoftwareTechnology Services DiaMed France SA provides serology services. The company was founded on December 5, 1979 and is headquartered in Marnes-la-Croquette, France. | Technology Services |
Bio-Rad AbD Serotec Ltd.
Bio-Rad AbD Serotec Ltd. Medical SpecialtiesHealth Technology Part of Bio-Rad Laboratories, Inc., Bio-Rad AbD Serotec Ltd. is a supplier and manufacturer of antibodies, reagents, and kits. The private company was founded in 1981 and is based in Kidlington, UK. Bio-Rad AbD Serotec offers custom antibody services and a range of products including veterinary research antibodies, ELISAs, and antibodies to CD markers and cytokines for various animal species. The British company's pioneer antibody discovery team provides a bespoke service tailored to each client's success criteria, from establishing project-specific functional assays to detailed characterization of clones. Bio-Rad AbD Serotec also implements an antibody validation initiative to identify nonspecific antibodies and accelerate scientific progress. | Health Technology |
Bio-Rad Laboratories AB
Bio-Rad Laboratories AB Medical SpecialtiesHealth Technology Bio-Rad Laboratories AB manufactures and distributes products for the life science research and clinical diagnostic markets. It develops and markets tools for genomics, proteomics, drug discovery, food safety, and medical diagnostics. The firm's customers encompass hospitals, references, transfusion and physician office laboratories, universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The company was founded in 1992 and is headquartered in Sundbyberg, Sweden. | Health Technology |
Clinical Diagnostics, Inc. | |
AdvaMedDx
AdvaMedDx Miscellaneous Commercial ServicesCommercial Services Part of Advanced Medical Technology Association, AdvaMedDx operates as a trade association representing diagnostics manufacturers. The private company is based in Washington. The CEO of the American company is Scott Whitaker. | Commercial Services |
Bio-Rad AbD Serotec GmbH
Bio-Rad AbD Serotec GmbH Medical SpecialtiesHealth Technology Part of Bio-Rad Laboratories, Inc., Bio-Rad AbD Serotec GmbH is a supplier and manufacturer of antibodies, reagents, and kits. The private company is based in Puchheim, Germany. The German company offers a wide range of custom antibody services, including bulk antibody production, antibody conjugation, and hybridoma production and services. The company's Pioneer Antibody Discovery team of scientists and technical specialists is assigned to every project to ensure a bespoke service tailored according to each client's success criteria. The CEOs of the company are Norman D. Schwartz, Lee Keron Marles. | Health Technology |
Bio-Rad Laboratories Ltd.
Bio-Rad Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Bio-Rad Laboratories Ltd. engages in research and manufacture of healthcare industry products. The private company is based in Watford, UK. | Commercial Services |
Bio-Rad Germany Holding GmbH
Bio-Rad Germany Holding GmbH Financial ConglomeratesFinance Bio-Rad Germany Holding GmbH engages in the acquisition, disposal, financing, holding, and management of direct and indirect participating interests in firms. It focuses on firms, which specialize in the production and distribution of medical, diagnostic, and other products. The company was founded on March 2, 2009 and is headquartered in Dreieich, Germany. | Finance |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Health Technology |
Bio-Rad Services UK Ltd.
Bio-Rad Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Bio-Rad Services UK Ltd. is a private company that specializes in developing, manufacturing, and marketing innovative products for the life science research and clinical diagnostic markets. The company is based in Watford, UK. The British company's products are verified for quality, purity, and performance through certificates of analysis (COAs), which can be obtained by catalog number and lot or batch number. | Commercial Services |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Health Technology |
Bio-Rad SAS
Bio-Rad SAS Miscellaneous Commercial ServicesCommercial Services Bio-Rad SAS is a French company that specializes in developing and manufacturing products for the life science research and clinical diagnostic markets. The private company is based in Marnes-la-Coquette, France. The company's focus is on accelerating biopharmaceutical and biotherapeutic method, process development, manufacturing, release testing, quality control, and patient monitoring with resources and workflows. The company is committed to helping the scientific community change the world through innovative products. The company was founded in 2012. Norman D. Schwartz has been the CEO of the company since 2021. | Commercial Services |
- Stock Market
- Insiders
- Norman Schwartz